Core Viewpoint - The article discusses the upcoming Fourth China Plastic Surgery and Regenerative Medicine Development Conference and the 14th Beijing International Aesthetic Surgery Conference, scheduled for October 31 to November 2, 2025, in Beijing, aiming to promote the development of plastic surgery and enhance collaboration among related disciplines [2][3]. Conference Overview - The conference will feature a main forum, an innovation transformation competition final, and nine sub-forums, with an expected attendance of around 500 participants [2]. - The event will include product exhibitions from various companies, and registration is free for attendees [2]. Main Forum Agenda - The main forum will commence with a welcome address and opening speeches from key figures in the medical and academic fields, including the Vice President of the Chinese Academy of Medical Sciences and the Chairman of the Beijing Eight Major Places Plastic Surgery Medical Technology Group [2]. - The agenda includes a series of thematic presentations covering topics such as the introduction of the Eight Major Places Plastic Surgery Medical Concept Verification Center, innovative medical technologies, and the commercialization of medical device innovations [3]. Innovation Transformation Competition - The afternoon session will host the third Plastic Surgery Innovation Transformation Competition final, showcasing innovative projects in plastic surgery and aesthetic medicine, providing a platform for clinical innovation [3]. Investment Forum - A dedicated investment sub-forum will take place on November 2, featuring discussions on the current state and opportunities in the aesthetic medicine industry, as well as trends in the light medical beauty sector [3][4]. - Notable speakers include investment managers and industry leaders who will share insights on various topics, including stem cell applications and the development of high-end domestic laser medical equipment [4]. Additional Sub-Forums - The conference will also host several sub-forums focusing on topics such as medical device safety and compliance, high-quality development of aesthetic institutions, and digital transformation in the medical beauty industry [4][5].

Core Viewpoint - The article discusses the upcoming Fourth China Plastic Surgery and Regenerative Medicine Development Conference and the 14th Beijing International Aesthetic Surgery Conference, scheduled for October 31 to November 2, 2025, in Beijing, aimed at promoting the development of plastic surgery in China and enhancing collaboration among related disciplines [3]. Event Details - The event will feature the Third Ba Da Chu Aesthetic Industry Forum, a competition final, and nine sub-forums [3]. - Participation is free, and there will be an exhibition of enterprise products on-site [4]. Hosting Organizations - The event is organized by Ba Da Chu Plastic Surgery Medical Concept Verification Center, Si Yu MedTech, Jin Yu Mao Wu, Tsinghua Technology Park Medical Engineering Cross-Innovation Center, and Zi Niu Fund [5]. Morning Session Highlights - The morning session includes various presentations, such as: - "Investment Perspective on the Current Status and Opportunities in the Medical Aesthetic Industry" by Sun Haisun, Investment Deputy General Manager, Jin Yu Mao Wu [5]. - "Trends in the Development of the Light Medical Aesthetic Industry" by Yu Bo, Partner, Zi Niu Fund [5]. - "Application of Stem Cells and Exosomes in Postoperative Wound Repair" by Zhao Yong, Chairman, Beizheng Saiou (Beijing) Biotechnology Co., Ltd. [5]. Afternoon Session Highlights - The afternoon session will cover topics including: - "Opportunities and Challenges for Domestic Medical Aesthetic Photonic Equipment Going Abroad" by Liao Ziyan, Brand Promotion Director, Suzhou Baifu Laser Technology Co., Ltd. [6]. - "New Generation Needle-Free Drug Delivery Technology in Domestic and International Medical Aesthetic Fields" by Zhou Ping, CTO, Zhuoyou Medical (Suzhou) Co., Ltd. [6]. - "Applications of Functional Nucleic Acid Nanotechnology in the Light Medical Aesthetic Industry" by Zhang Kaiping, Marketing Center General Manager, Beijing Xingyilian Technology Co., Ltd. [6]. Registration Information - Interested participants can register by scanning a QR code or clicking a link provided at the end of the article [6].

Core Insights - The second Medical Device R&D Forum was successfully held at the Medtec 2025 International Medical Device Design and Manufacturing Technology Exhibition, highlighting the growth and internationalization of China's medical device industry [2][4] - The forum emphasized the importance of collaboration between hospitals and the industry to drive innovation and technology transfer [8][34] Group 1: Forum Highlights - Zhao Qing, founder of SiYu MedTech, stated that Medtec focuses on the "source" of medical devices, serving as a platform for industry exchange and innovation acceleration [2] - Gu Xiaoyuan, General Manager of Informa Group's Medical Health & IP Licensing, noted that Medtec China has been a key player in the medical device industry for over 20 years, facilitating industry communication and international cooperation [4] Group 2: Innovation and Technology Transfer - Lei Juan, Director of the Sichuan West Medical Technology Transfer Center, shared experiences in transforming scientific achievements into products, emphasizing the role of hospitals as sources of technology transfer [8] - Cao Gangyi, CEO of Huanxin Medical, discussed the complexities of cardiovascular interventional devices and the importance of clinical needs in product design and patent strategy [10] - Wang Kai from Nankai University presented advancements in vascular injury repair and regeneration materials, showcasing their potential applications in vascular reconstruction [12] Group 3: Industry Collaboration and New Materials - Wang Hanxuan, a scientist from Switzerland, analyzed how large companies like Novartis create value through innovation and the role of international technology clusters in promoting R&D and industry cycles [14] - Shi Chen, CEO of InnoCo, shared the development journey of Chro-Mg™ controlled degradation magnesium alloy, which offers new possibilities for orthopedic devices [16] Group 4: Supply Chain and Compliance - Zhao Qing provided an overview of the medical device supply chain and emphasized its vulnerabilities, urging upstream companies to collaborate with manufacturers for innovative product development [18] - Shi Daifeng, Technical Director at China Inspection and Testing International, highlighted the importance of considering testing points early in the R&D process to avoid registration delays [20] Group 5: Emerging Trends and AI Integration - Zhou Gui, General Manager of Beijing Lila Technology, discussed the application of PDRN in implantable agents within the aesthetic medicine sector, indicating the potential for cross-industry material expansion [22] - Han Chen, Co-founder of Beijing Haisheng Medical Devices, presented the research and clinical exploration of fully degradable stents for diabetic patients, aiming to attract attention from hospitals and investors [24] - Zhang Bowei, CTO of Vascular Cube Medical Device Incubator, explored new models for medical device innovation incubation, particularly in peripheral vascular and cardiac pacing fields [26] Group 6: Future Outlook - The forum brought together experts from hospitals, research institutions, innovative companies, testing agencies, and incubation platforms to discuss materials, patents, standards, clinical applications, and international experiences [34] - The discussions reflected the transition of China's medical device industry from "following" to "running alongside and leading," with SiYu MedTech committed to fostering industry communication and documenting innovation growth [34]

Core Viewpoint - The second Medical Device R&D Innovation Forum will be held during the Medtec China 2025 exhibition in Shanghai, focusing on product innovation pathways and implementation mechanisms [2][3]. Agenda Summary Morning Session - Opening remarks will commence at 09:30, followed by various presentations including: - Exploration of medical-engineering integration in research hospitals by Lei Juan, highlighting innovation and transformation [2] - Discussion on new interventional technologies and related patents by Cao Gangyi, CEO of Huanxin Medical [2] - Successful practices in building multi-level medical technology clusters presented by Wang Hanxuan, a Swiss PSI scientist [2] - Research on vascular injury repair and regenerative materials by Wang Kai from Nankai University [2] - Current status and innovative thoughts on ultrasonic energy surgical instruments by Feng Gengchao, founder of Shenzhen Segasys Medical Technology [2] - Development and transformation of Chro-Mg™ time-controlled degradable magnesium alloy by Shi Chen, CEO of InnoCo [2]. Afternoon Session - The afternoon will feature additional presentations starting at 13:30, including: - Overview of the entire medical device R&D process and overseas case studies by Zhao Qing, founder of Siyu MedTech [3] - Key points on medical device testing and compliance standards by Shi Daifeng, Technical Director at China Inspection Huatuo [4] - Applications and efficacy of PDRN (salmon-derived beauty injections) in aesthetic implants by Zhou Gui, General Manager of Beijing Lila Technology [4] - Discussion on fully degradable stents for diabetic below-knee artery intervention by Han Chen, co-founder of Beijing Haisheng Medical Devices [4] - Exploration of the starting point for medical device innovation incubation by Zhang Bowei, CTO of Vascular Cube Medical Device Incubation Platform [4] - Trends in vascular reduction technology presented by Wang Yang, founder and General Manager of Jintai Medical [4] - Applications and practices of common polymer biomaterials in implantable medical devices by Guan Zenggang, R&D Director at Haiwang Medical [4] - AI-assisted planning for structural heart interventional surgeries by Xue Zhenling, General Manager of Xixin Technology [4].

Core Viewpoint - The second Medical Device R&D Innovation Forum will be held during the Medtec China 2025 exhibition in Shanghai, focusing on product innovation pathways and implementation mechanisms [2][3]. Morning Agenda Summary - The forum will feature various presentations, including topics such as the integration of medical engineering in research hospitals, new interventional technologies, and the development of biodegradable magnesium alloys [2][3][4]. - Key speakers include: - Lei Juan, discussing the exploration of innovation and transformation in medical engineering [2]. - Cao Gangyi, presenting on new interventional technologies and related patents [2]. - Wang Hanxuan, sharing successful practices from the Basel pharmaceutical valley [2]. - Wang Kai, focusing on vascular injury repair and regenerative materials [2]. - Feng Gengchao, addressing the current status and innovative thoughts on ultrasonic energy surgical instruments [2]. - Shi Chen, discussing the R&D and transformation of Chro-Mg™ controlled degradation magnesium alloys [2]. Afternoon Agenda Summary - The afternoon session will cover topics such as the full process of medical device R&D, compliance standards, and applications of PDRN in aesthetic medicine [3][4]. - Notable presentations include: - Zhao Qing, discussing the full process of medical device R&D and overseas cases [3]. - Shi Daifeng, sharing key points on medical device testing and compliance [4]. - Zhou Gui, presenting on the application and efficacy of PDRN in implantable agents [4]. - Han Chen, discussing the use of fully biodegradable stents for diabetic patients [4]. - Zhang Bowei, exploring the starting point for medical device innovation incubation [4]. - Wang Yang, addressing trends in vascular reduction technology [4]. - Guan Zenggang, discussing the application and practice of common polymer biomaterials in implantable medical devices [4]. - Xue Zhenling, presenting on AI-assisted planning for structural heart interventional surgeries [4].

Group 1 - The second Medical Device R&D Innovation Forum will be held during the Medtec China 2025 exhibition in Shanghai, focusing on product innovation pathways and implementation mechanisms [2] - The forum is organized by Siyu MedTech and Informa Markets' Medtec China team, inviting industry leaders and experts to share insights [2] - The agenda includes various presentations on topics such as medical technology integration, new intervention techniques, and the development of biodegradable materials [3][4] Group 2 - The morning session features speakers from various organizations discussing topics like the integration of medical engineering in research hospitals and innovations in surgical ultrasound devices [3] - The afternoon session includes discussions on high-quality development in the medical health industry and the application of PDRN in aesthetic medicine [4] - Attendees can register for free to participate in the forum by filling out a registration form [4]